Susceptibility to false discovery in biomarker research using liquid chromatography–high resolution mass spectrometry based untargeted metabolomics profiling

• Pengwei Zhang,
• Irene L. Ang,
• Melody M.T. Lam,
• Rui Wei,
• Kate M.K. Lei,
• Xingwang Zhou,
• Henry H.N. Lam,
• Qing‐Yu He,
• Terence C.W. Poon

Affiliations

Pengwei Zhang

The First Affiliated Hospital & MOE Key Laboratory of Tumor Molecular Biology Jinan University Guangzhou China

Irene L. Ang

Pilot Laboratory Institute of Translational Medicine Centre for Precision Medicine Research and Training Faculty of Health Sciences University of Macau Macau China

Melody M.T. Lam

Proteomics Core Institute of Translational Medicine Faculty of Health Sciences University of Macau Macau China

Rui Wei

Pilot Laboratory Institute of Translational Medicine Centre for Precision Medicine Research and Training Faculty of Health Sciences University of Macau Macau China

Kate M.K. Lei

Pilot Laboratory Institute of Translational Medicine Centre for Precision Medicine Research and Training Faculty of Health Sciences University of Macau Macau China

Xingwang Zhou

Department of Biochemistry and Molecular Biology Zhongshan School of Medicine Sun Yat‐Sen University Guangzhou China

Henry H.N. Lam

Department of Chemical and Biological Engineering Hong Kong University of Science and Technology Hong Kong China

Qing‐Yu He

The First Affiliated Hospital & MOE Key Laboratory of Tumor Molecular Biology Jinan University Guangzhou China

Terence C.W. Poon

Pilot Laboratory Institute of Translational Medicine Centre for Precision Medicine Research and Training Faculty of Health Sciences University of Macau Macau China